Answers are grounded in this paper and cite their sources.
This is the first study that describes a cost-utility analysis to compare unilateral with simultaneous bilateral CI in postlingually deafened adults, using a multicenter RCT. Compared with accepted societal willingness-to-pay thresholds, simultaneous bilateral CI is a cost-effective treatment for patients with a life expectancy of 5-10 years or longer.
No takes yet. Share an insight, caveat, or question.
Smulders et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: